QT
ABCL icon

Quantamental Technologies’s AbCellera Biologics ABCL Stock Holding History

Quantamental Technologies’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$90K Buy
+19,570
New +$119K 0.08% 258
2022
Q4 		– Sell
-11,999
Closed -$119K – 436
2022
Q3 		$119K Sell
11,999
-11,976
-50% -$131K 0.05% 448
2022
Q2 		$255K Buy
+23,975
New +$203K 0.12% 299
2022
Q1 		– Sell
-12,080
Closed -$173K – 355
2021
Q4 		$173K Buy
+12,080
New +$183K 0.09% 344

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Quantamental Technologies's ABCL Position: Q3 2023 in Review

Quantamental Technologies opened a new position in AbCellera Biologics (ABCL) in Q3 2023: 19,570 shares worth $90K. The stake represents 0.08% of the portfolio and ranks #258 among its holdings. This is a return to the name: Quantamental Technologies previously reported a position in ABCL as recently as Q3 2022.

Quantamental Technologies first reported a position in ABCL in Q4 2021 and has held it in 4 quarters since. The position peaked at $255K in Q2 2022. 138 funds tracked by Wall St. Rank hold ABCL as of Q3 2023.

  • Quantamental Technologies held 19,570 shares of AbCellera Biologics worth $90K as of Q3 2023.
  • AbCellera Biologics was a new Quantamental Technologies position in Q3 2023.
  • AbCellera Biologics made up 0.08% of Quantamental Technologies's portfolio in Q3 2023, its #258 holding.
  • Quantamental Technologies first reported a position in AbCellera Biologics in Q4 2021 and has held it in 4 quarters since.
  • Quantamental Technologies's AbCellera Biologics position peaked at $255K in Q2 2022.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.